Financial Planning for Orthopedic Surgeons: The Complete 2026 Guide

Orthopedic surgery is the highest-earning specialty in medicine — and the one with the most complex financial architecture. ASC equity, practice partnership buy-ins, subspecialty income variance, malpractice tail costs, and $600K–$1.5M income levels create a planning environment that most financial advisors have never navigated. This guide covers the full career arc from fellowship through exit.

The Orthopedic Income Arc

Orthopedic surgeons earn more than any other specialty by MGMA benchmarks — but the distribution spans a wide range depending on subspecialty, practice model, and career stage. Understanding this arc is essential to planning correctly at each phase.

The ASC column is transformative. A surgeon with a 20% stake in a well-run orthopedic ASC typically receives $300K–$700K in annual distributions on top of clinical compensation — distributions that are taxed at long-term capital gain rates rather than ordinary income. This is why the choice of where and how to practice is the single most important financial decision most orthopedic surgeons will make.

Subspecialty matters enormously. Spine surgeons command the highest incomes ($875K+ median per MGMA 2025), while pediatric and trauma surgeons earn considerably less. Use the subspecialty lifetime income comparator to model the 30-year wealth gap across subspecialties and practice settings — for some career paths, the difference exceeds $5M in present value.

Stage 1 — Fellowship & First Attending Contract

Fellowship-to-attending is the highest-leverage financial transition of the career. Three decisions made here have 30-year consequences.

Student Loan Strategy

Most orthopedic surgeons carry $250–400K in medical school debt at the end of fellowship. The decision point is binary:

• PSLF (Public Service Loan Forgiveness): Qualifies if you join an academic center or a non-profit/governmental hospital system. After 10 years of qualifying payments, the remaining balance is forgiven tax-free. For a surgeon joining a 501(c)(3) hospital at $650K, PSLF can be worth $200–350K in forgiven debt. The math is compelling when income is high and the loan balance is large.
• Refinance & pay off: The correct choice for private practice surgeons who won't qualify for PSLF. Refinance to a competitive rate and retire the debt aggressively over 3–5 years. Don't carry $350K in student loans at 6–7% while earning $900K.

Key 2026 note: The SAVE repayment plan ended in March 2026. IBR is currently the operative IDR plan for those pursuing PSLF; the new RAP plan launches July 1, 2026. See the orthopedic surgeon student loan guide for the full decision framework.

First Employment Contract: What's Actually Negotiable

The contract you sign at your first attending position sets your compensation floor for years. Key provisions ortho surgeons routinely under-negotiate:

• wRVU conversion factor. MGMA 2025 median for orthopedic surgery: ~$48–55/wRVU depending on subspecialty. Below-market conversion factors cost you $50–150K/year and compound over the guarantee period.
• Guarantee period. A guarantee without a wRVU benchmark is a ceiling — once you exceed the guarantee, the extra productivity just fills the employer's liability. Negotiate a clear productivity path above guarantee.
• Non-compete scope. The FTC's 2024 non-compete rule was vacated in September 2025. State law now governs. A 2-year, 20-mile non-compete from a hospital paying $700K is a contingent $1.8M liability on your balance sheet — it affects where you can live, who you can see, and your negotiating power if you ever want to leave.
• Malpractice tail coverage. Who pays the tail when you leave? For a spine surgeon with 5 years of practice history, tail can cost $80–150K. This should be explicitly addressed in the contract.
• ASC ownership rights. If the employer is developing or owns an ASC, your right to invest and on what terms should be in the contract from day one — not negotiated ad hoc after you've built a surgical practice there.

See the employment contract negotiation guide for a full checklist by employer type.

Disability Insurance: The Fellowship Timing Window

The single most financially important insurance purchase most orthopedic surgeons will ever make is an individual, own-occupation disability policy — and the best time to buy it is during fellowship. Here's why:

• Premiums are set at your age at issue. A 32-year-old fellow pays materially less per $1K of monthly benefit than a 35-year-old attending.
• Guaranteed Standard Issue (GSI) offers are available to fellows at most training programs — no individual underwriting, which matters enormously if you've had any joint, back, or hand issues during residency/fellowship.
• Own-occupation definition is non-negotiable for surgeons. A modified own-occ definition that allows the insurer to reduce benefits if you can do "any" medical work is inadequate — if you can't operate, you need the benefit, regardless of whether you could do administrative work.

Target benefit: $20–25K/month for most ortho attendings. Stacking individual policies to $40–50K/month is appropriate for top-earning surgeons. See the disability insurance guide for the full analysis.

Year-One Financial Checklist

When you start attending:

• Max 401(k)/403(b) — $24,500 in 2026¹
• If hospital-employed at non-profit/governmental: also max the 457(b) — another $24,500
• Backdoor Roth IRA — $7,500/year (all ortho attendings earn above the $242K–$252K MFJ Roth income phaseout)
• Open HSA if your health plan is HDHP-eligible — $8,750 family in 2026²
• Establish 3–6 month emergency fund (minimum $150K for most attendings before taking on additional financial complexity)
• Life insurance: $3–5M term policy, 20-year term for most new attendings

See the complete new attending financial checklist.

Stage 2 — Associate to Partner (Years 1–5)

This is where orthopedic surgeons make the two highest-stakes financial decisions of their careers.

The Partnership Buy-In: Is It Worth It?

Typical orthopedic private practice buy-ins: $200–400K in capital contributions over 2–3 years, usually financed via a practice-issued promissory note at modest interest rates. The financial case for partnership:

• Partner income is typically 40–70% higher than associate income after buy-in completion at well-run private groups.
• Equity value. Your ownership stake accrues value as the practice grows and/or when you eventually sell. At $1–3M EBITDA practices, a 20% stake is worth $400K–$900K to a physician buyer (2–5× EBITDA), significantly more to a PE buyer (6–12×).
• ASC equity access. Partnership almost always unlocks the ASC investment opportunity, which is often worth more than the practice equity itself.

Use the partnership buy-in analyzer to model your specific offer. The key variables: current associate income, projected partner income, buy-in amount, financing terms, and whether ASC equity is included. See also the orthopedic group partnership agreement guide for the legal and structural terms that matter most.

ASC Investment: The Career's Highest-Value Decision

For most orthopedic surgeons, an ambulatory surgery center equity stake is the single most impactful wealth-building decision they'll make. The economics:

• Buy-in cost: $200K–$500K for an established ASC. New ASC development: $300K–$700K in capital calls over 2 years for a fractional stake.
• Annual distributions: $200K–$500K+ per surgeon-owner at a well-run orthopedic ASC. Spine-heavy ASCs at the high end; sports medicine ASCs at the lower end.
• Break-even timeline: 1.5–3 years in most scenarios (distributions pay back the buy-in, then it's profit).
• Tax treatment: ASC distributions flow as K-1 income from the entity, taxed at long-term capital gain rates in most structures — significantly better than ordinary income on W-2 compensation.
• Exit value: Corporate ASC buyers (USPI, SurgCenter Development, AmSurg, HCA) pay 6–12× EBITDA multiples. A surgeon with $300K in annual distributions and a 20% stake may see $1.5–3M at exit.

Use the ASC investment ROI calculator to model your specific opportunity. For surgeons whose group is building a new facility, see the de novo ASC development guide.

Entity Structure and Tax Optimization

Once you're receiving partnership distributions and/or 1099 income (locum tenens, expert witness, device consulting), entity structure matters significantly:

• S Corporation (or PC/PLLC electing S): Partnership distributions and 1099 income through an S Corp structure saves SE tax on the portion above "reasonable compensation." At $600K+ total income with $200K in K-1 distributions, SE tax savings can be $12–25K/year.
• § 199A QBI deduction: Physicians are an SSTB (specified service trade or business). The 20% QBI deduction phases out completely for MFJ filers between $394,600 and $544,600 (2026, post-OBBBA). Most attending orthopedic surgeons are entirely above this phaseout — the deduction is unavailable. But S Corp distributions may reduce W-2 income enough for early-career surgeons near the phaseout to capture partial benefit. See the tax planning guide.
• PTET elections: 36+ states allow pass-through entity tax elections that move state income tax to the entity level. For practice-owning surgeons, this circumvents the $10K SALT cap (effective for all ortho surgeons earning $600K+ after the OBBBA phaseout). Savings: $15K–$45K/year in federal taxes. See the PTET guide.

Stage 3 — Mid-Career Peak Earning (Years 5–20)

This is when the tax problem gets serious and the wealth-building opportunity is largest. Most mid-career orthopedic surgeons are at 37% federal marginal rate. The priority order:

1. Max all tax-advantaged space first. The 2026 stack can shelter $100K–$290K+ annually before taxable investing. See below.
2. Build liquid assets equal to at least 2× your practice/ASC equity. Most surgeons over-concentrate in their own surgical ecosystem. If 80% of net worth is in practice and ASC equity, a bad outcome in either creates catastrophic concentration risk.
3. Estate planning at $5M+ net worth. Grantor trusts, ILITs, and annual gifting strategies become relevant well before the $15M federal exemption (permanent post-OBBBA). State exemptions vary widely.
4. Insurance review. Update disability benefit to current income. Umbrella liability at $3–10M. Review life insurance as estate and buy-sell exposures change.

The 2026 Tax-Advantaged Stack

For a private-practice orthopedic surgeon netting $900K+, the complete 2026 contribution stack:

A 55-year-old private-practice spine surgeon can contribute $72,000 (401k + profit-sharing) + $220,000 (cash balance plan) + $9,750 (HSA) + $8,500 (backdoor Roth) = approximately $310,000 in tax-deferred and tax-free savings annually. At a 37% marginal rate, this saves roughly $115,000 in current-year federal taxes alone.

The cash balance plan is the key lever. Most hospital-employed surgeons can't access one; private practice owners can. See the cash balance plan guide for the contribution table by age and the 415(b) limits. For surgeons with any 1099 income — locum tenens, expert witness, consulting — a solo 401(k) on that income source adds another employer contribution on top of the practice plan.

Other key tax strategies in this stage:

• Roth conversions during income dips. If you have a sabbatical year, transition year, or partial-volume year before RMDs begin, the bracket arbitrage window is significant. See Roth conversion strategy.
• Real estate investing. The REPS (Real Estate Professional Status) exception is unavailable to full-time surgeons (750-hour test + >50% personal-services requirement). But the short-term rental loophole (average rental period ≤7 days + material participation) and passive REITs/syndications work. OBBBA permanently restored 100% bonus depreciation for property placed in service after January 19, 2025. See real estate investing guide.
• Tax-loss harvesting and direct indexing. At the 23.8% federal LTCG + NIIT rate (20% + 3.8% NIIT above $518,900 MFJ), systematic loss harvesting on a $2–5M taxable account saves $20–50K+ annually. See investment strategy guide.
• Tax deductions. Every deductible dollar — malpractice premiums, CME, professional dues, health insurance (Form 7206 for owners), LTC insurance (age-based IRS limits) — matters at 37%. See the complete tax deductions guide.

Stage 4 — Late Career & Exit Planning

The Roth Conversion Window

Most orthopedic surgeons accumulate large pre-tax retirement balances ($1.5–4M is common at late career) from decades of 401(k) + cash balance plan contributions. When practice income drops — during the partial-volume phase or after selling the practice — there's a window to convert pre-tax dollars to Roth at lower rates before RMDs begin at age 73 (born 1951–1959) or 75 (born 1960+).

A surgeon who retires at 60 and waits until 75 for RMDs has a 15-year Roth conversion window. Converting $200–300K/year during this period at 24–32% marginal rate, vs. paying 37% on forced RMDs later (compounded to $3–5M by RMD age), can save $400–700K in lifetime taxes. Model the specific cases at Roth conversion strategy.

Practice Sale

Most orthopedic practices transact in one of three ways:

• Physician-to-physician sale: 2–5× EBITDA multiples. Simpler structure, often asset purchase with § 197 goodwill amortization for the buyer over 15 years.
• Hospital or health system acquisition: Varies widely by market. Often employment agreements rather than true sales; income guarantees may compensate but the economics differ from a true exit.
• Private equity acquisition: 6–12× EBITDA multiples at letter of intent, with a mandatory 20–30% rollover equity component. The rollover equity is the "second bite" — if the PE sponsor achieves a 2–3× on the platform, your $300K in rollover equity becomes $600K–900K at a second transaction 4–6 years later. See the private equity in orthopedics guide and the practice sale guide.

Use the practice sale calculator to model your specific transaction's net proceeds after federal LTCG (23.8%), state tax, and deal structure.

ASC Stake Exit

ASC corporate buyers pay 6–10× EBITDA on distributions. A surgeon generating $400K in annual ASC distributions with a 20% stake in an ASC earning $5M EBITDA might receive $6–10M at exit (20% × $30–50M enterprise value). This is often the largest single wealth event in an orthopedic career.

Timing matters: if you sell within the same year as your practice, the combined gain is taxed in a single high-income year. Consider installment sales or QOZ investing to manage the gain. The December 31, 2026 deadline for existing QOZ 1.0 investors is approaching — see the QOZ guide.

Malpractice Tail on Transition

Claims-made policies leave surgeons exposed to claims filed after the policy lapses unless tail coverage is purchased. For a spine surgeon with 10 years of practice history, tail typically costs 200–250% of the final year's annual premium — often $80–150K. This is often negotiable in contract exit provisions. Estimate your exposure with the malpractice tail cost calculator.

Social Security and IRMAA Planning

Most orthopedic surgeons have 14+ "zero years" in their Social Security wage history from training — this reduces the Average Indexed Monthly Earnings calculation and ultimately the benefit. Delaying claiming to age 70 adds 8%/year in credits beyond FRA (age 67 for those born 1960+), and the 2026 max benefit at age 70 is $5,181/month (verified SSA.gov).³

IRMAA (Income-Related Medicare Adjustment Amount) adds $81–487/month per person to Part B premiums based on income 2 years prior. A surgeon who sells a practice in 2026 will face top-tier IRMAA surcharges in 2028. Plan for this spike — and use the SSA Form SSA-44 Life-Changing Event appeal if income drops significantly after the high-income year. See IRMAA and Medicare planning.

Estate Planning

The OBBBA (One Big Beautiful Bill Act, July 2025) permanently set the federal estate and gift tax exemption at $15M per person ($30M MFJ). This eliminated the 2026 sunset that had been scheduled to cut exemptions in half. But state estate taxes are separate and often have lower thresholds ($1–2M in some states). Key tools at $5M–$30M net worth:

• Irrevocable Life Insurance Trust (ILIT) — removes life insurance proceeds from taxable estate
• Annual gifting — $19K per recipient per year (2026)⁴, plus superfunding 529 accounts at $95K per beneficiary
• Buy-sell agreement funding for practice and ASC equity
• Grantor trusts for income-producing assets

See estate planning for orthopedic surgeons.

Subspecialty Financial Considerations

Financial planning strategy differs meaningfully by subspecialty. The high-level distinctions:

• Spine surgeons: Highest income ceiling ($875K+ median), highest malpractice premiums ($80–120K/yr + $160–300K tail), most attractive PE acquisition target, highest ASC distribution potential due to case mix. Detailed: spine surgeon financial planning.
• Joint replacement surgeons: Strong ASC opportunity post-2020 CMS expansion; robotics capital call considerations; career longevity compresses the peak earning window to ~16 years (ages 40–56). Detailed: joint replacement surgeon financial planning.
• Sports medicine surgeons: Best career longevity profile (30+ year active career); team physician contract economics; QBI § 199A optimization possible at lower income levels near the phaseout. Detailed: sports medicine surgeon financial planning.
• Trauma surgeons: PSLF is often the right loan strategy (Level I/II trauma centers are usually 501(c)(3) health systems); 403(b)+457(b) double-stack adds up to $49K/yr in employee deferral at governmental hospitals; call compensation is the primary income lever. Detailed: trauma surgeon financial planning.
• Hand & upper extremity surgeons: Own-occupation disability is an existential risk — fine motor function is the revenue engine; hand cases generate top ASC margins in ortho. Detailed: hand surgeon financial planning.
• Foot & ankle surgeons: Podiatry competition affects practice valuation and ASC structure; CMS expansion enables ankle arthroplasty at ASC. Detailed: foot & ankle surgeon financial planning.
• Pediatric ortho surgeons: PSLF dominates (most work at 501(c)(3) children's hospitals); ASC ownership is limited; statute of limitations on minors creates longer malpractice exposure tail. Detailed: pediatric ortho surgeon financial planning.
• Academic surgeons: NIH salary cap ($228K), PSLF math, Bayh-Dole IP royalties, and device consulting restrictions under 42 CFR Part 50 create a distinct planning landscape. Detailed: academic surgeon financial planning.

The 7 Biggest Financial Mistakes Orthopedic Surgeons Make

1. Not modeling the 5-year private practice alternative before signing a hospital employment contract. Hospital pays more year 1. Private practice often pays 40–70% more by year 5 — with ASC equity on top. Use the total-comp calculator to compare.
2. Skipping or delaying the ASC investment because the buy-in feels large. At a healthy ASC, distributions pay back the entire buy-in in 1.5–3 years. Every year of delay forfeits that income permanently.
3. Refinancing student loans before evaluating PSLF. Hospital-employed surgeons pursuing PSLF can receive $200–350K in tax-free forgiveness. Refinancing eliminates eligibility — this is an irreversible decision.
4. Not buying disability insurance during fellowship. The GSI window closes at graduation. Individual underwriting as an attending — with any prior back, knee, or hand issues — can result in exclusions or denial. The policy is much more expensive at 38 than at 31.
5. Using a generalist advisor who doesn't understand ASC economics. Most advisors treat ASC distributions as just "investment income." A specialist models the K-1 tax treatment, operating agreement buyout constraints, distribution reinvestment vs. diversification trade-off, and corporate buyer optionality. See how to choose an advisor for the 5 ortho-specific expertise signals.
6. Not establishing a cash balance plan as a private practice owner. A 55-year-old surgeon who waits until age 60 to establish a cash balance plan loses 5 years of $150–200K+ annual contributions that would compound tax-free. See cash balance plan guide.
7. Over-concentrating in practice + ASC equity. If 80% of net worth is in your own surgical ecosystem, a bad outcome — market dislocation, competition, career-ending injury, or PE deal falling through — is catastrophic. Build liquid financial assets systematically during peak earning years. See investment strategy guide.

Finding the Right Financial Advisor

Most financial advisors — including those who call themselves "physician-focused" — lack the specific expertise orthopedic surgery requires: ASC distribution modeling, wRVU contract analysis, partnership buy-in evaluation, cash balance plan design, and PE acquisition deal mechanics. A generalist physician advisor will not model an ASC investment correctly or know which corporate buyers are paying what multiples in your market.

The standard you should hold any prospective advisor to:

• Fee-only (fiduciary, no product commissions)
• Can walk you through an ASC cash-on-cash return calculation without notes
• Has read a partnership agreement and explained the redemption formula to you
• Knows what "EBITDA normalization" means in the context of a practice sale
• Can explain when a cash balance plan makes sense vs. doesn't (staff coverage rules, PBGC premiums)

See the full guide: how to choose a financial advisor for orthopedic surgeons. And for tax-side decisions: how to choose a CPA for orthopedic surgeons.

Sources

1. IRS — 2026 401(k) and profit-sharing plan contribution limits ($24,500 employee deferral; $72,000 overall 415(c) limit). IRS Notice 2025-67.
2. IRS Publication 969 — HSA contribution limits 2026 ($4,400 self-only / $8,750 family; $1,000 catch-up at 55+). IRS Rev. Proc. 2025-19.
3. SSA — Retirement benefit age reduction and delayed retirement credits. 2026 maximum benefit at age 70: $5,181/month.
4. IRS — 2026 annual gift tax exclusion ($19,000 per recipient). IRS Rev. Proc. 2025-49.
5. AAOS / MGMA 2025 Physician Compensation Survey — orthopedic surgeon income benchmarks by subspecialty (2024 actuals).
6. Federal Student Aid — Public Service Loan Forgiveness (PSLF) program eligibility and qualifying employer requirements.
7. Ambulatory Surgery Center Association — ASC industry data, ownership structures, and financial benchmarks.

Tax limits and contribution figures verified against 2026 IRS guidance. Income benchmarks from MGMA 2025 Physician Compensation Survey (2024 actuals). ASC distribution and valuation ranges reflect industry data and are region-specific — consult a specialist for your market. Values verified June 2026.